Showing 18,101 - 18,120 results of 45,793 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 18101
  2. 18102

    DataSheet3_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  3. 18103

    DataSheet2_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  4. 18104

    DataSheet1_Investigation of anti-diabetic effect of a novel coenzyme Q10 derivative.ZIP by Xiaojun Tan (548013)

    Published 2023
    “…Moreover, L-50 could increase fasting insulin levels (FINS) in HFD/STZ mice, leading to a decrease in fasting blood glucose (FBG) and hepatic glycogen. …”
  5. 18105
  6. 18106
  7. 18107

    Docking results of effective compounds in TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  8. 18108

    Active compounds screened from TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  9. 18109

    Network of compound-target-pathway. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  10. 18110
  11. 18111

    Table_1_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.DOCX by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  12. 18112

    Image_1_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.TIFF by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  13. 18113

    Image_3_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.TIFF by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  14. 18114

    Image_2_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.TIFF by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  15. 18115

    Table_3_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.DOCX by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  16. 18116

    Table_2_Attenuating Sulfidogenesis in a Soured Continuous Flow Column System With Perchlorate Treatment.XLSX by Anna L. Engelbrektson (5560358)

    Published 2018
    “…To determine if (per)chlorate could sweeten a soured column system and assign a quantitative value to each of the mechanisms we treated columns flooded with San Francisco bay water with temporally decreasing amounts (50, 25, and 12.5 mM) of (per)chlorate. …”
  17. 18117

    Data Sheet 1_Efficacy and safety of Tanshinone capsule in Acne vulgaris: a systematic review and meta-analysis.docx by Yutong Deng (20908982)

    Published 2025
    “…We found that Tanshinone capsules can reduce acne recurrence rates [risk ratio (RR) 0.44, 95% confidence interval (CI): 0.34 to 0.57, p < 0.00001]; downregulate levels of necrosis factor-alpha (TNF-α) [ mean difference (MD) 0.44, −10.18, 95% CI: −13.57 to −8.04, p < 0.00001], interleukin (IL) 4 (MD -6.46, 95%CI: −7.14 to −5.77, p < 0.00001), IL-6 (MD -16.14, 95%CI: −30.10 to −2.18, p = 0.02), IL-8 (MD -4.48, 95%CI: −8.30 to −0.65, p = 0.02) and testosterone (MD -14.50, 95%CI: −17.59 to −11.40, p < 0.00001); lower Global Acne Grading System (GAGS) score (MD -4.71, 95%CI: −7.62 to −1.80, p = 0.002); decrease sebum secretion rates (MD -0.29, 95%CI: −0.49 to −0.10, p = 0.003), but the regulation of Luteinizing hormone (LH), Follicle-stimulating hormone (FSH), Estradiol (E<sub>2</sub>) is not obvious. …”
  18. 18118
  19. 18119

    Supplementary Material for: Endovascular thrombectomy with or without bridging thrombolysis in acute ischemic stroke: A cost-effectiveness analysis by Morsi R.Z. (17739816)

    Published 2024
    “…Background There is unclear added benefit of intravenous thrombolysis (IVT) with endovascular thrombectomy (EVT). We performed a cost-effectiveness analysis to assess the cost-effectiveness comparing EVT with IVT versus EVT alone. …”
  20. 18120

    The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review by Sarah Elshahat (8587107)

    Published 2020
    “…Mean EuroQol-5D index scores ranged from 0.80 to 0.86 for CKD stages 1–3, and decreased to 0.73–0.79 for CKD stages 4–5. …”